New Zealand markets closed

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
7.53+0.15 (+2.03%)
At close: 04:00PM EST
7.40 -0.13 (-1.73%)
After hours: 07:49PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 21.74M
Enterprise value 1.22B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.01
Price/book (mrq)1.55
Enterprise value/revenue 0.39
Enterprise value/EBITDA -1.33

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-96.40%
S&P500 52-week change 314.90%
52-week high 3226.00
52-week low 35.27
50-day moving average 315.09
200-day moving average 389.27

Share statistics

Avg vol (3-month) 3179.21k
Avg vol (10-day) 3114.04k
Shares outstanding 52.89M
Implied shares outstanding 65.41M
Float 81.8M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (14 Nov 2023) 4755.7k
Short ratio (14 Nov 2023) 42.18
Short % of float (14 Nov 2023) 429.97%
Short % of shares outstanding (14 Nov 2023) 426.17%
Shares short (prior month 12 Oct 2023) 4262.66k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 302 Nov 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -18.63%
Operating margin (ttm)-11.67%

Management effectiveness

Return on assets (ttm)-14.23%
Return on equity (ttm)-429.35%

Income statement

Revenue (ttm)3.1B
Revenue per share (ttm)1,192.10
Quarterly revenue growth (yoy)18.50%
Gross profit (ttm)421.69M
EBITDA -288.42M
Net income avi to common (ttm)-577.76M
Diluted EPS (ttm)-228.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)41.33M
Total cash per share (mrq)14.45
Total debt (mrq)1.24B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.40
Book value per share (mrq)-43.16

Cash flow statement

Operating cash flow (ttm)-146.84M
Levered free cash flow (ttm)39.19M